Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Nov;37(11):1678-84.
doi: 10.1007/BF01299858.

Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways

Affiliations
Comparative Study

Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways

S Fiorucci et al. Dig Dis Sci. 1992 Nov.

Abstract

The effect of administering different doses of erythromycin on gallbladder emptying and plasma concentrations of immunoreactive motilin was investigated in healthy volunteers. Erythromycin was infused for 30 min at four different doses: 20, 50, 100, and 1000 mg/hr. Gallbladder volume was determined by ultrasound scanning every 10 min for 60 min. All doses, except 20 mg/hr, provoked a significant reduction in gallbladder volume (P < 0.01). The gallbladder emptying peak occurred after 20 min infusion. It was approximately 40-45% of basal volume and 60-70% of the emptying observed after a standard meal. At 100 mg/hr, erythromycin caused a 2.5-fold increase in plasma motilin concentration, which reached a peak after 30 min infusion. Plasma motilin peaked following maximum gallbladder emptying in all subjects. To evaluate whether cholinergic pathways were implicated in the action of erythromycin, 100 mg/hr erythromycin was infused together with 6 micrograms/kg/hr atropine. Atropine inhibited both gallbladder emptying and motilin release (P < 0.001). Infusion of 1 microgram/kg/hr somatostatin had the same inhibitory effects (P < 0.001). Our results suggest that atropine acts by inhibiting an erythromycin-activated cholinergic neural mechanism. Somatostatin could exert its inhibitory effect by blocking the release of acetylcholine from neural terminations.

PubMed Disclaimer

References

    1. Am J Physiol. 1981 Feb;240(2):G183-9 - PubMed
    1. J Pharmacol Exp Ther. 1990 Sep;254(3):940-4 - PubMed
    1. Am J Physiol. 1990 Sep;259(3 Pt 1):G355-63 - PubMed
    1. Am J Physiol. 1984 Dec;247(6 Pt 1):G688-94 - PubMed
    1. AJR Am J Roentgenol. 1985 Nov;145(5):1009-11 - PubMed

Publication types

MeSH terms